Financials
Financial year 2025
Apotheek VESALIUS from Roeselare, company number BE0440159274, closed financial year 2025 with a result of € 51,173 after tax. For that financial year Apotheek VESALIUS recorded a gross margin of € 247,719 and equity of € 509,158. Compared with financial year 2024, the result moved from € 49,122 to € 51,173. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 17, 2026.
€ 509,158
▲ 11% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 51,173
▲ 4% vs 2024
Profit after tax over the fiscal year.
€ 665,927
▲ 275% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 447,158.
People and assets in 2025
1.9
Average over the fiscal year, from the social balance sheet.
€ 145,285
▲ 4% vs 2024
€ 76,500 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
€ 304,000
▲ 6% vs 2024
Loans from banks and other lenders, long and short.
€ 62,509
▼ 14% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 29,310
▼ 9% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 214,725 | € 213,786 | € 246,115 | € 247,719 | ▲ 1% |
| Profit after taxes | € 24,511 | € 14,612 | € 49,122 | € 51,173 | ▲ 4% |
| Equity | € 394,251 | € 408,863 | € 457,985 | € 509,158 | ▲ 11% |
| Total debts | € 375,561 | € 387,969 | € 409,721 | € 411,590 | |
| Cash | € 443,573 | € 143,356 | € 177,444 | € 665,927 | ▲ 275% |
| Land & buildings | € 80,521 | € 67,101 | € 53,681 | € 40,261 | ▼ 25% |
| Retained profit | € 332,251 | € 346,863 | € 395,985 | € 447,158 | ▲ 13% |
| Bank debt | € 277,000 | € 277,000 | € 288,000 | € 304,000 | ▲ 6% |
| Balance sheet total | € 769,812 | € 796,832 | € 867,706 | € 920,748 | ▲ 6% |
| Employees (FTE) | 1.8 | 1.9 | 1.9 | 1.9 |
Key figures of Apotheek VESALIUS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Apotheek VESALIUS?
What happened at Apotheek VESALIUS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Johan Vaneeckhout stepped down as director. NBB
- Vesalius BV stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 51,173 (▲ 4% vs 2024). Source: NBB ↗
- Johan Vaneeckhout became a director. NBB
- Vesalius BV became a director. NBB
- New establishment in Roeselare. KBO
- Start of the company according to the CBE. KBO
In short
From € 24,511 profit in 2022 to € 51,173 profit in 2025.
Paid € 52,044 in corporate taxes since 2022.
Best year ever: 2025, with € 51,173 profit.
On average € 130,400 of value added per employee in 2025.
Management
Directors
According to the 2025 annual accounts
since 2022 · until 2028
Managing director, Chairman of the board, Director · represented by Grietje Van Wesel
since 2022 · until 2028
Establishments
Establishment units
Physical locations of this company
Iepersestraat 288 box A
8800 Roeselare
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0440.159.274
- VAT number
- BE 0440.159.274
- Registered office
- Iepersestraat 288 bus A, 8800 Roeselare
- Names & denominations
- Apotheek VESALIUS
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 23 February 1990
- Peppol
- Active · Active since 29 Aug 2023
- Activities · NACE
Apothekers
Detailhandel in farmaceutische producten